After Covishield, India’s Covaxin gets expert panel nod for emergency use

An expert panel of India’s drug authority on Saturday recommended restricted emergency use of Bharat Biotech’s Covaxin. The development comes a day after the panel recommended emergency use authorisation for the Serum Institute of India’s (SII) Covishield.An expert panel of India’s drug authority on Saturday recommended restricted emergency use of Bharat Biotech’s Covaxin. The development comes a day after the panel recommended emergency use authorisation for the Serum Institute of India’s (SII) Covishield.